May 24 (Reuters) - Cyclopharm Ltd (CYC) :
- TECHNEGAS SHOWN TO HAVE A KEY ROLE IN DIAGNOSIS AND MANAGEMENT OF COVID-19
- FINDINGS INCLUDED ROLE OF TECHNEGAS IN DIAGNOSIS & ONGOING MANAGEMENT OF LONG COVID SYMPTOMS
News: CYC Cyclopharm Says Technegas Shown To Have Key Role In COVID-19 Diagnosis & Management
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
-0.050(3.13%) |
Mkt cap ! $172.2M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.60 | $1.55 | $13.25K | 8.366K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 539 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 2806 | 1 |
View Market Depth
| Last trade - 15.59pm 24/07/2024 (20 minute delay) ? |
| CYC (ASX) Chart |